Transforming growth factor-β in breast cancer: A working hypothesis
- 1 August 1997
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 45 (1), 81-95
- https://doi.org/10.1023/a:1005865812918
Abstract
Transforming Growth Factor-beta (TGF beta) is the most potent known inhibitor of the progression of normal mammary epithelial cells through the cell cycle. During the early stages of breast cancer development, the transformed epithelial cells appear to still be sensitive to TGF beta-mediated growth arrest, and TGF beta can act as an anti-tumor promoter. In contrast, advanced breast cancers are mostly refractory to TGF beta-mediated growth inhibition and produce large amounts of TGF beta, which may enhance tumor cell invasion and metastasis by its effects on extracellular matrix. We postulate that this seemingly paradoxical switch in the responsiveness of tumor cells to TGF beta during progression is the consequence of the activation of the latent TGF beta that is produced and deposited into the tumor microenvironment, thereby driving the clonal expansion of TGF beta-resistant tumor cells. While tumor cells themselves may activate TGF beta, recent observations suggest that environmental tumor promoters or carcinogens, such as ionizing radiation, can cause stromal fibroblasts to activate TGF beta by epigenetic mechanisms. As the biological effects of the anti-estrogen tamoxifen may well be mediated by TGF beta, this model has a number of important implications for the clinical uses of tamoxifen in the prevention and treatment of breast cancer. In addition, it suggests a number of novel approaches to the treatment of advanced breast cancer.Keywords
This publication has 63 references indexed in Scilit:
- The role of TGF‐β production in growth inhibition of breast‐tumor cells by progestinsInternational Journal of Cancer, 1995
- Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.Genes & Development, 1993
- TGFβ induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effectsJournal of Cellular Physiology, 1993
- Regulation of mammary morphogenesis: Evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-β1Developmental Biology, 1992
- Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breastEuropean Journal Of Cancer, 1992
- Localization of transforming growth factor-β isotypes in lesions of the human breastHuman Pathology, 1992
- Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland developmentDevelopment, 1991
- Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.Proceedings of the National Academy of Sciences, 1990
- Effects of transforming growth factor β on growth of human mammary epithelial cells in cultureIn Vitro Cellular & Developmental Biology, 1989
- Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice.The Journal of cell biology, 1989